Steba Biotech Ltd.

Steba Biotech Ltd. is a leading pharmaceutical manufacturing company specializing in innovative photodynamic therapy (PDT) solutions for prostate cancer treatment. Steba Biotech Ltd. utilizes a sophisticated technique that enables the targeted destruction of tissue through the administration of a light-sensitive agent (photosensitizer) and the local application of light in the presence of oxygen. This approach allows for precise and effective cancer treatment.

Steba Biotech Ltd. is dedicated to advancing cancer treatment methodologies through continuous research and development. The company's photodynamic therapy involves the photosensitizer absorbing light generated by a laser, transferring this energy to surrounding tissues, and triggering cell destruction. Steba Biotech Ltd. aims to improve patient outcomes and quality of life through its innovative therapeutic solutions.

Steba Biotech Ltd. is committed to upholding the highest standards in pharmaceutical manufacturing and clinical research. The company's focus on photodynamic therapy positions it as a key player in the evolving landscape of cancer treatment. More information on Steba Biotech Ltd.'s advancements will be completed soon with the support of the company’s management.

We invite the manager of Steba Biotech Ltd. to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative work.